Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
Plumb ID, Fette LM, Tjaden AH, Feldstein L, Saydah S, Ahmed A, Link-Gelles R, Wierzba TF, Berry AA, Friedman-Klabanoff D, Larsen MP, Runyon MS, Ward LM, Santos RP, Ward J, Weintraub WS, Edelstein S, Uschner D. Plumb ID, et al. Among authors: wierzba tf. Vaccine. 2023 Apr 6;41(15):2596-2604. doi: 10.1016/j.vaccine.2023.03.006. Epub 2023 Mar 9. Vaccine. 2023. PMID: 36932031 Free PMC article.
Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership.
Berry AA, Tjaden AH, Renteria J, Friedman-Klabanoff D, Hinkelman AN, Gibbs MA, Ahmed A, Runyon MS, Schieffelin J, Santos RP, Oberhelman R, Bott M, Correa A, Edelstein SL, Uschner D, Wierzba TF; COVID-19 Community Research Partnership. Berry AA, et al. Among authors: wierzba tf. Vaccine X. 2023 Aug 11;15:100371. doi: 10.1016/j.jvacx.2023.100371. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37649617 Free PMC article.
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021.
Bagamian KH, Puett C, Anderson JD 4th, Muhib F, Pecenka C, Behrman J, Breiman RF, Edoka I, Horton S, Kang G, Kotloff KL, Lanata CF, Platts-Mills JA, Qadri F, Rogawski McQuade ET, Sudfeld C, Vonaesch P, Wierzba TF, Scheele S. Bagamian KH, et al. Among authors: wierzba tf. Vaccine X. 2022 Sep 21;12:100218. doi: 10.1016/j.jvacx.2022.100218. eCollection 2022 Dec. Vaccine X. 2022. PMID: 36237199 Free PMC article.
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership.
Friedman-Klabanoff DJ, Tjaden AH, Santacatterina M, Munawar I, Sanders JW, Herrington DM, Wierzba TF, Berry AA; COVID-19 Community Research Partnership. Friedman-Klabanoff DJ, et al. Among authors: wierzba tf. Vaccine. 2022 Oct 6;40(42):6133-6140. doi: 10.1016/j.vaccine.2022.09.021. Epub 2022 Sep 12. Vaccine. 2022. PMID: 36117003 Free PMC article. Clinical Trial.
Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership.
Williamson JC, Wierzba TF, Santacatterina M, Munawar I, Seals AL, Pittman Ballard CA, Alexander-Miller M, Runyon MS, McCurdy LH, Gibbs MA, Ahmed A, Lagarde WH, Maguire PD, King-Thiele R, Hamrick T, Ihmeidan A, Henderson S, Gallaher TR, Uschner D, Edelstein SL, Herrington DM, Sanders JW; North Carolina sites of the COVID-19 Community Research Partnership. Williamson JC, et al. Among authors: wierzba tf. PLoS One. 2022 Mar 18;17(3):e0260574. doi: 10.1371/journal.pone.0260574. eCollection 2022. PLoS One. 2022. PMID: 35302997 Free PMC article.
117 results